Medexus Pharmaceuticals Inc has shown modest price movement this week amidst steady trading volumes and no major news announcements.
As of today, Medexus Pharmaceuticals Inc (MDP.TO) closed at C$5.00, reflecting a slight increase of 0.59% over the past week. The stock has gained 1.19% in the last month and an impressive 65.70% year-to-date, indicating a positive trend in investor sentiment despite a lack of recent news.
Investor takeaway: Investors may find Medexus Pharmaceuticals an interesting option given its strong year-to-date performance and the recent product launch of GRAFAPEX, although it is important to consider the company's ongoing financial challenges.
Advertisement
Medexus Pharmaceuticals Inc
MDP.TO
MDP.TO
Medexus Pharmaceuticals Inc
WealthAwesomeMarket cap
$160.90M
52W high
$5.50
52W low
$2.51
1W change
+0.59%
Beta
1.83
Analyst Price Targets
Based on analyst covering MDP · as of Sep 17, 2026
Wall Street analysts forecast MDP stock price to rise 41.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.25
+41.6% Upside
Current Price
C$5.12
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDP's historical volatility
30-Day Vol
23.4%
Annualized
90-Day Vol
37.8%
Annualized
Trend (90d)
-8.9%
Annualized drift
90d Mean
C$4.96
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$5.07 | C$4.67 – C$5.49 |
| 60 trading days | C$5.01 | C$4.47 – C$5.62 |
| 90 trading days | C$4.96 | C$4.31 – C$5.70 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$5.00: Current Share Price
The stock is currently trading at the lower end of its 52-week range of C$2.51 to C$5.50, suggesting there may be room for growth if the company can capitalize on its recent product performance.
Bull case
Analysts are optimistic about Medexus, with an average target price of C$7.25. This suggests a potential upside of 45% from the current price. The positive financial results from the U.S. launch of GRAFAPEX also enhance confidence in the company’s growth prospects.
Bear case
However, Medexus Pharmaceuticals faces challenges with negative profit margins and return on equity, indicating ongoing financial struggles. The stock is also more volatile than the market, with a beta of 1.83, which may pose risks for conservative investors.
Price Action Overview
Advertisement
Medexus Pharmaceuticals Inc (MDP.TO) closed at C$5.00, with a daily change of 0.00%. Over the last week, the stock has increased by 0.59%, while it has gained 1.19% over the past month. Year-to-date, the stock has performed exceptionally well, up 65.70%. The trading volume today was 38,303 shares, which is slightly above the 20-day average volume of 32,664 shares, indicating solid investor interest.
Recent Company News
There were no major news announcements from Medexus Pharmaceuticals this week. However, the company recently held its annual meeting where shareholders elected all nominated directors and approved the appointment of PricewaterhouseCoopers LLP as auditors. This event reflects the company's ongoing governance efforts. Additionally, Medexus has previously reported positive results from the U.S. launch of GRAFAPEX, which may have contributed to its favorable stock performance.
Technical Picture
Technically, Medexus is trading close to its 50-day moving average of C$5.09, which is down 1.7% from the current price. The stock's 200-day moving average stands at C$3.89, indicating a solid 28.6% gain relative to the current price. The stock is currently trading at 83% of its 52-week range of C$2.51 to C$5.50. With a beta of 1.83, MDP.TO is considered more volatile than the broader market, which could attract risk-tolerant investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
